Table 2.

Details of samples collected during phase 1 (March 2021 to October 2021) which met the inclusion criteria.

Sl. No.	Category (phase 1)	Number	Percentage (%)
1	Cluster	281	40.03
2	High TPR area	143	20.37
3	Infection after Single dose vaccine	56	7.98
4	Infection after Two doses of vaccine	212	30.20
5	Patient with no co-morbidity in ICU	1	0.14
6	Reinfection	6	0.85
7	Traveler from abroad	3	0.43